Advertisement
Screener

Foghorn Therapeutics Inc. (FHTX) Construction Payable, Current

2.8 / 5 stars · 68/120 Roast Me

Foghorn Therapeutics Inc. Construction Payable, Current

Foghorn Therapeutics Inc. (FHTX) had Construction Payable, Current of $2.38 million as of 2020-12-31, per its 10-K filed 2021-03-18.

Discontinued › Notes

us-gaap:ConstructionPayableCurrent · last filed 2021-03-18

  • 2020-12-31: Construction Payable, Current $2.38M.
  • 2020-09-30: Construction Payable, Current $6.21M.
  • 2019-12-31: Construction Payable, Current $119.00K.
Period endConstruction Payable, Current
2020-12-31$2.38M
10-K · filed 2021-03-18
2020-09-30$6.21M
10-Q · filed 2020-12-04
2019-12-31$119.00K
10-K · filed 2021-03-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
Eledon Pharmaceuticals, Inc. (ELDN)United States$0.219B-3.23
Whitehawk Therapeutics, Inc. (WHWK)United States$0.221B
Nkarta, Inc. (NKTX)United States$0.205B-1.73
NATURES SUNSHINE PRODUCTS INC (NATR)United States$0.228B20.51
ORAMED PHARMACEUTICALS INC. (ORMP)$0.199B1.13
Keros Therapeutics, Inc. (KROS)United States$0.229B-2.55
Zentalis Pharmaceuticals, Inc. (ZNTL)United States$0.196B-2.48
Cartesian Therapeutics, Inc. (RNAC)United States$0.231B-2.04
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37